BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/7/2019 1:35:59 AM | Browse: 784 | Download: 1178
 |
Received |
|
2019-09-08 10:09 |
|
Peer-Review Started |
|
2019-09-08 10:10 |
|
To Make the First Decision |
|
2019-09-19 06:45 |
|
Return for Revision |
|
2019-09-20 10:03 |
|
Revised |
|
2019-09-26 14:27 |
|
Second Decision |
|
2019-10-28 10:42 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-11-01 01:48 |
|
Articles in Press |
|
2019-11-01 01:48 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-11-05 02:19 |
|
Publish the Manuscript Online |
|
2019-11-07 01:35 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Disease monitoring strategies in inflammatory bowel diseases: What do we mean by ‘tight control’?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Lorant Gonczi, Talat Bessissow and Peter Laszlo Lakatos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Peter Laszlo Lakatos, DSc, FRCP (C), MD, Full Professor, Staff Physician, Division of Gastroenterology, McGill University Health Centre, Montreal General Hospital C7-200,
1650 Cedar Avenue, Montreal H3G1A4, Quebec, Canada. kislakpet99@gmail.com |
| Key Words |
Crohn’s disease; Ulcerative colitis; Treat-to-target; Tight control; Monitorting; Biomarker |
| Core Tip |
Inflammatory bowel diseases are chronic, progressive, immune-mediated disorders leading to disability and cumulative intestinal damage. There has been a major change in treatment paradigms favouring an early introduction of highly effective therapies, applying a treat-to-target approach to target composite clinical and endoscopical therapeutic endpoints and using close monitoring of objective markers of inflammation (with clinical, endoscopical and biomarker assessment) to direct therapeutic decisions until these goals are reached. Although several data support the benefit of ‘treat-to-target’ and ‘tight control’ strategies so far, these approaches require further validation assessing long-term outcomes and more precise definition of therapeutic targets (for both endoscopic and biomarker monitoring). |
| Publish Date |
2019-11-07 01:35 |
| Citation |
Gonczi L, Bessissow T, Lakatos PL. Disease monitoring strategies in inflammatory bowel diseases: What do we mean by ‘tight control’?. World J Gastroenterol 2019; 25(41): 6172-6189 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i41/6172.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i41.6172 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
